|
1
|
Dendrou CA, Fugger L and Friese MA:
Immunopathology of multiple sclerosis. Nat Rev Immunol. 15:545–558.
2015.PubMed/NCBI View
Article : Google Scholar
|
|
2
|
Howard J, Trevick S and Younger DS:
Epidemiology of multiple sclerosis. Neurol Clin. 34:919–939.
2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Lublin FD, Reingold SC, Cohen JA, Cutter
GR, Sørensen PS, Thompson AJ, Wolinsky JS, Balcer LJ, Banwell B,
Barkhof F, et al: Defining the clinical course of multiple
sclerosis: The 2013 revisions. Neurology. 83:278–286.
2014.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Compston A and Coles A: Multiple
sclerosis. Lancet. 372:1502–1517. 2008.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Tabansky I, Messina MD, Bangeranye C,
Goldstein J, Blitz-Shabbir KM, Machado S, Jeganathan V, Wright P,
Najjar S, Cao Y, et al: Advancing drug delivery systems for the
treatment of multiple sclerosis. Immunol Res. 63:58–69.
2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Giovannoni G, Butzkueven H, Dhib-Jalbut S,
Hobart J, Kobelt G, Pepper G, Sormani MP, Thalheim C, Traboulsee A
and Vollmer T: Brain health: Time matters in multiple sclerosis.
Mult Scler Relat Disord. 9 (Suppl 1):S5–S48. 2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Durelli L, Conti L, Clerico M, Boselli D,
Contessa G, Ripellino P, Ferrero B, Eid P and Novelli F: T-helper
17 cells expand in multiple sclerosis and are inhibited by
interferon. Ann Neurol. 65:499–509. 2009.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Langrish CL, Chen Y, Blumenschein WM,
Mattson J, Basham B, Sedgwick JD, McClanahan T, Kastelein RA and
Cua DJ: IL-23 drives a pathogenic T cell population that induces
autoimmune inflammation. J Exp Med. 201:233–240. 2005.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Kebir H, Kreymborg K, Ifergan I,
Dodelet-Devillers A, Cayrol R, Bernard M, Giuliani F, Arbour N,
Becher B and Prat A: Human TH17 lymphocytes promote blood-brain
barrier disruption and central nervous system inflammation. Nat
Med. 13:1173–1175. 2007.PubMed/NCBI View
Article : Google Scholar
|
|
10
|
Tzartos JS, Friese MA, Craner MJ, Palace
J, Newcombe J, Esiri MM and Fugger L: Interleukin-17 production in
central nervous system-infiltrating T cells and glial cells is
associated with active disease in multiple sclerosis. Am J Pathol.
172:146–155. 2008.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Rolla S, Bardina V, De Mercanti S,
Quaglino P, De Palma R, Gned D, Brusa D, Durelli L, Novelli F and
Clerico M: Th22 cells are expanded in multiple sclerosis and are
resistant to IFN-β. J Leukoc Biol. 96:1155–1164. 2014.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Tachovsky TG, Lisak RP, Koprowski H,
Theofilopoulos AN and Dixon FJ: Circulating immune complexes in
multiple sclerosis and other neurological diseases. Lancet.
2:997–999. 1976.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Jacques C, Davous P and Baumann N:
Circulating immune complexes and multiple sclerosis. Lancet.
2(408)1977.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Goust JM, Chenais F, Carnes JE, Hames CG,
Fudenbergh HH and Hogan HL: Abnormal T cell subpopulations and
circulating immune complexes in the Guillain-Barré syndrome and
multiple sclerosis. Neurology. 28:421–425. 1978.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Deicher H, Schwabedissen HM, Liman W,
Baruth B, Patzold U and Haller P: Immune complexes in cerebrospinal
fluid and serum of patients with multiple sclerosis. In: Progress
in Multiple Sclerosis Research. Bauer HG, Poser S and Ritter G
(eds). Verlag, Berlin, Springer, pp200-206, 1980.
|
|
16
|
Jans H, Jersild C, Taaning E, Dybkjaer E,
Fog T and Heltberg A: The occurrence of immune complexes in
patients with multiple sclerosis. In: Progress in Multiple
Sclerosis Research. Bauer HG, Poser S and Ritter G (eds). Verlag,
Berlin, Springer, pp195-199, 1980.
|
|
17
|
Schocket AL, Carr RI and Hardtke MA: A
comparison of I125 Clq binding, Raji cell binding, and
lymphocytotoxic activity in multiple sclerosis. Clin Immunol
Immunopathol. 17:477–481. 1980.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Trouillas P, Vincent C and Revillard JV:
Clq binding circulating immune complexes in multiple sclerosis
patients and their first-degree relatives: A distinctive
immunological feature between sporadic and familial cases. J Clin
Lab Immunol. 4:77–81. 1980.PubMed/NCBI
|
|
19
|
Noronha AB, Antel JP, Roos RP and Medof
EM: Circulating immune complexes in neurologic disease. Neurology.
31:1402–1407. 1981.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Tanaka Y, Tsukada N, Koh CS and Yanagisawa
N: Anti-endothelial cell antibodies and circulating immune
complexes in the sera of patients with multiple sclerosis. J
Neuroimmunol. 17:49–59. 1987.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Dasgupta MK, Warren KG, Johny KV and
Dossetor JB: Circulating immune complexes in multiple sclerosis:
Relation with disease activity. Neurology. 32:1000–1004.
1982.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Tsukada N, Koh CS, Yanagisawa N and
Tsukagoshi H: Nervous tissue injury induced by immune complexes.
Acta Neuropathol. 56:279–284. 1982.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Broman T: Blood-brain barrier damage in
multiple sclerosis. Supravital test-observation. Acta Neurol Scand
Suppl. 40 (Suppl 10):S21–S24. 1964.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Aita JF, Benette DR, Anderson RE and Ziter
F: Cranial CT appearance of acute multiple sclerosis. Neurology.
28:251–255. 1978.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Lane B, Carrol BA and Pedley TA:
Computerized cranial tomography in cerebral diseases of white
matter. Neurology. 28:534–544. 1978.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Ebers GC, Vinuela FV, Feasby T and Bass B:
Multifocal CT enhancement in MS. Neurology. 34:341–346.
1984.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Hershey LA, Gado MH and Trotter JL:
Computerized tomography in the diagnostic evaluation of multiple
sclerosis. Ann Neurol. 5:32–39. 1979.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Dasgupta MK, Catz I, Warren KG, McPherson
TA, Dossetor JB and Carnegie PR: Myelin basic protein: A component
of circulating immune complexes in multiple sclerosis. Can J Neurol
Sci. 10:239–243. 1983.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Carson JH, Barbarese E, Braun PE and
McPherson TA: Components in multiple sclerosis cerebrospinal fluid
that are detected by radioimmunoassay for myelin basic protein.
Proc Natl Acad Sci USA. 75:1976–1978. 1978.PubMed/NCBI View Article : Google Scholar
|
|
30
|
McPherson TA, Gilpin A and Seland TP:
Radioimmunoassay of CSF for encephalitogenic basic protein: A
diagnostic test for MS? Can Med Assn J. 107:856–859.
1972.PubMed/NCBI
|
|
31
|
Panitch HS, Hafler DA and Johnson KP:
Antibodiestomyelin basic protein in cerebrospinal fluid of patients
with multiple sclerosis. In: Progress in Multiple Sclerosis
Research. Bauer HJ, Poser SR and Ritter G (eds). Springer-Verlag,
Heidelberg, New York, pp98-105, 1980.
|
|
32
|
Tachovsky TG, Koprowski H, Lisak RP,
Theofilopoulos AN and Dixon FJ: Circulating immune complexes in
multiple sclerosis and other neurological diseases. Lancet.
308:997–999. 1976.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Patzold U, Haller P, Baruth B, Liman W and
Deicher H: Immune complexes in multiple sclerosis: Relation to
clinical pattern. J Neurol. 222:249–260. 1980.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Jans H, Heltberg A, Zeeberg I, Kristensen
JH, Fog T and Raun NE: Immune complexes and the complement factors
C4 and C3 in cerebrospinal fluid and serum from patients with
chronic progressive multiple sclerosis. Acta Neurol Scand.
69:34–38. 1984.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Wajgt A, Górny MK and Jenek R: The
influence of high-dose prednisone medication on autoantibody
specific activity and on circulating immune complex level in
cerebrospinal fluid of multiple sclerosis patients. Acta Neurol
Scand. 68:378–385. 1983.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Munger KL, Levin LI, Hollis BW, Howard NS
and Ascherio A: Serum 25-hydroxyvitamin D levels and risk of
multiple sclerosis. JAMA. 296:2832–2838. 2006.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Mowry EM, Krupp LB, Milazzo M, Chabas D,
Strober JB, Belman AL, McDonald JC, Oksenberg JR, Bacchetti P and
Waubant E: Vitamin D status is associated with relapse rate in
pediatric-onset multiple sclerosis. Ann Neurol. 67:618–624.
2010.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Bhargava P, Steele SU, Waubant E,
Revirajan NR, Marcus J, Dembele M, Cassard SD, Hollis BW,
Crainiceanu C and Mowry EM: Multiple sclerosis patients have a
diminished serologic response to vitamin D supplementation compared
to healthy controls. Mult Scler. 22:753–760. 2016.PubMed/NCBI View Article : Google Scholar
|
